vimarsana.com

Latest Breaking News On - Tom riga - Page 3 : vimarsana.com

Spectrum Pharmaceuticals Provides Update on ROLVEDON (eflapegrastim-xnst) Injection and Announces Unaudited Fourth Quarter 2022 Financial Results

31.01.2023 - Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology, today announced business highlights and preliminary ROLVEDON net sales for the quarter and year ended December 31, 2022. Business . Seite 1

Spectrum Pharmaceuticals Announces Management Changes

Spectrum Pharmaceuticals Announces Management Changes
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

FDA Passes on Poziotinib for NSCLC With HER2 Exon 20 Insertions

The FDA has issued a complete response letter to Spectrum Pharmaceuticals regarding the new drug application for poziotinib.

FDA Passes on Poziotinib for HER2 Exon 20 Insertion Mutation Positive NSCLC

The FDA has issued a Complete Response Letter to Spectrum Pharmaceuticals regarding the New Drug Application for poziotinib.

Spectrum (SPPI) de-prioritizes poziotinib after receiving CRL from FDA, shares drop

Spectrum (SPPI) de-prioritizes poziotinib after receiving CRL from FDA, shares drop
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.